CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
TECNIS® TORIC II Intraocular Lens (IOL)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04210232
NCT04210232N/ACompleted
CompareCT.gov

Post-market Evaluation of Surgeon Feedback on TECNIS® TORIC II Intraocular Lens (IOL)

Johnson & Johnson Surgical Vision, Inc.·interventional·Posted Dec 24, 2019·Updated Oct 12, 2021

In Brief

A clinical study evaluating TECNIS® TORIC II Intraocular Lens (IOL) for Cataract and Corneal Astigmatism. Completed, enrolled 54 participants across 12 sites.

Detailed Summary

This is a multicenter, prospective, single-arm, open-label, clinical study of the commercially available TECNIS Toric II, Model ZCU IOL. The study will be conducted in up to 1100 subjects enrolled with 1,000 subjects needing unilateral or bilateral cataract surgery across up to 50 US study sites.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract, Corneal Astigmatism
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 24, 2019
Enrollment StartJan 14, 2020
Primary CompletionSep 11, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 6.5 years ago

Interventions

TECNIS® TORIC II Intraocular Lens (IOL)device

Surgeons will perform standardized, small-incision, cataract surgery and implant in one or both eyes the study lenses.